Jennifer Fox
Gerontology · Flemington, NJNPI 1225450950
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $49,544 of the $75,597 with a category attached, or 65.5%. 24 manufacturers reported payments, led by Alnylam Pharmaceuticals Inc. at 45.2% of the total. 2025 is the largest year on record at $38,028, more than ten times the $1,423 reported in 2021. Among gerontology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 314 payments — averaging $240.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alnylam Pharmaceuticals Inc.$34K
- Actelion Pharmaceuticals US, Inc.$26K
- E.r. Squibb & Sons, L.L.C.$8K
- Merck$2K
- United Therapeutics Corporation$1K
- Boehringer Ingelheim$1K
- plus $3K from 18 others
What the payments were for
- Consulting fees$2,0403%
- Speaking & faculty fees$49,54466%
- Travel & lodging$12,84617%
- Food & beverage$10,76614%
- Education$4021%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 73 | $34,193 |
| Actelion Pharmaceuticals US, Inc. | 95 | $26,420 |
| E.r. Squibb & Sons, L.L.C. | 31 | $7,747 |
| Merck | 14 | $1,573 |
| United Therapeutics Corporation | 19 | $1,140 |
| Boehringer Ingelheim | 24 | $1,050 |
| ZOLL Respicardia, Inc. | 2 | $668 |
| AstraZeneca | 12 | $473 |
| Abbott | 6 | $360 |
| Bayer | 7 | $318 |
| Analog Devices Inc. | 4 | $300 |
| Impulse Dynamics (USA) Inc. | 3 | $262 |
| Boston Scientific | 6 | $218 |
| Pfizer | 5 | $168 |
| Daxor Corporation | 3 | $168 |
| Scpharmaceuticals Inc. | 1 | $140 |
| Johnson & Johnson | 1 | $112 |
| Sanofi-aventis U.S. LLC | 1 | $108 |
| Amgen | 2 | $55 |
| Novartis | 1 | $52 |
| Sanofi | 1 | $25 |
| Cvrx, Inc. | 1 | $20 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| Akcea Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$75,597 in reported general payments places this provider in the 95th percentile of 374 gerontology providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyndamaxTafamidis | 31 | $681,258 |
| WinrevairSotatercept-Csrk | 11 | $273,421 |
| OpsumitMacitentan | 15 | $189,074 |
| CamzyosMavacamten | 23 | $187,124 |
| AdempasRiociguat | 13 | $157,329 |
| EntrestoSacubitril/Valsartan | 57 | $84,888 |
| AdcircaTadalafil | 15 | $76,626 |
| JardianceEmpagliflozin | 53 | $71,954 |
| EliquisApixaban | 49 | $52,354 |
| FarxigaDapagliflozin Propanediol | 29 | $36,926 |
| XareltoRivaroxaban | 20 | $25,086 |
| Everolimus | 12 | $10,685 |
| Sildenafil Citrate | 23 | $5,733 |
| Torsemide | 54 | $2,339 |
| Metoprolol Succinate | 94 | $1,332 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerVyndamax, Eliquis | $168 | $733,61180 claims |
| MerckWinrevair | $1,573 | $273,42111 claims |
| Actelion Pharmaceuticals US, Inc.Opsumit | $26,420 | $189,07415 claims |
| E.r. Squibb & Sons, L.L.C.Camzyos | $7,747 | $187,12423 claims |
| BayerAdempas | $318 | $157,32913 claims |
| NovartisEntresto | $52 | $84,88857 claims |
| United Therapeutics CorporationAdcirca | $1,140 | $76,62615 claims |
| Boehringer IngelheimJardiance | $1,050 | $71,95453 claims |
| AstraZenecaFarxiga | $473 | $36,92629 claims |
| Johnson & JohnsonXarelto | $112 | $25,08620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 374 gerontology providers in New Jersey.
Other gerontology in Flemington
- Dana JonesTeaneck$150K
- Susan HermidaBrick$33K
- Jihane SaadeNorth Bergen$9K
- Joseph RudolphCamden$8K
- Jennifer LernerNew Brunswick$7K
- Josephine MachadoNew Brunswick$7K
- Remya JamesNew Brunswick$7K
- Anna HaEnglewood$7K
- Myoung ParkBayonne$7K
- Maria Christina ErrazoEast Orange$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.